Teva Pharms. USA, Inc. v. Mylan Pharms. Inc.
| Decision Date | 29 June 2012 |
| Docket Number | Nos. 08 Civ. 7611 (BSJ) (AJP), 09 Civ. 8824 (BSJ) (AJP).,s. 08 Civ. 7611 (BSJ) (AJP), 09 Civ. 8824 (BSJ) (AJP). |
| Citation | 876 F.Supp.2d 295 |
| Parties | TEVA PHARMACEUTICALS USA, INC., et al., Plaintiffs, v. SANDOZ, INC., et al., Defendants. Teva Pharmaceuticals USA, Inc., et al., Plaintiffs, v. Mylan Pharmaceuticals Inc., et al., Defendants. |
| Court | U.S. District Court — Southern District of New York |
OPINION TEXT STARTS HERE
David M. Hashmall, Goodwin Procter, LLP, Elizabeth J. Holland, Miriam London Martinez, Steven Jeffrey Lee, Carolyn Anne Blessing, Patrice Polyxene Jean, Kenyon & Kenyon, Jeffrey A. Simes, Jonathan Aaron Auerbach, Joseph B. Crystal, Goodwin Procter, LLP, Brian Jeffrey Eutermoser, Weil, Gotshal & Manges LLP, New York, NY, Daryl L. Wiesen, John T. Bennett, Nicholas K. Mitrokostas, Goodwin Procter, LLP, Boston, MA, William G. James, II, Kenyon & Kenyon LLP, Washington, DC, for Plaintiffs.
Anders T. Aannestad, Brian Matthew Kramer, David C. Doyle, Morrison & Foerster LLP, San Diego, CA, Karen Louise Hagberg, Richard B. Mills-Robertson, Morrison & Foerster LLP, Andrew Levine, Friedman, Kaplan, Seiler & Adelman LLP, Beth D. Jacob, Schiff Hardin LLP, New York, NY, David L. Anstaett, Sarah C. Walkenhorst, Perkins Coie LLP, Madison, WI, Ricardo Solano, Jr., Friedman, Kaplan, Seiler & Adelman LLP, Newark, NJ, for Defendants.
To continue reading
Request your trial
-
Janssen Prods., L.P. v. Lupin Ltd.
...is "an inextricable and essential part of what doctors are prescribing" when they prescribe Prezista. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 416–17 (S.D.N.Y.2012), aff'd, 723 F.3d 1363 (Fed.Cir.2013), cert. granted on other issues, ––– U.S. ––––, 134 S.Ct. 1761, 188 L.Ed......
-
AstraZeneca LP v. Breath Ltd.
...and effective drug often supports the nonobviousness of a drug that finally achieves success.” Teva Pharma. USA, Inc. v. Sandoz, Inc., 876 F.Supp.2d 295, 417 (S.D.N.Y.2012). AstraZeneca introduced evidence of its own failures to create the claimed budesonide compositions using conventional ......
-
Depomed, Inc. v. Actavis Elizabeth LLC
...the patents may be demonstrated by an ANDA filer's certification and Notice Letter to the patent holder. Teva Pham. U.S.A., Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 349 (S.D.N.Y 2012). In assessing whether an asserted noninfringing use is substantial, the factfinder considers not only the......
-
Chin–McKenzie v. Continuum Health Partners
... ... Defendants Continuum Health Partners, Inc. (Continuum) and Long Island College Hospital ... See Amnesty Int'l USA v. Clapper, 638 F.3d 118, 129 n. 13 (2d ... ...
-
Supreme Court To Consider Federal Circuit De Novo Review Of Claim Construction In Teva Pharmaceuticals USA Inc. V. Sandoz Inc.
...that a person of ordinary skill in the art would know to use the peak average molecular weight. Teva Pharm. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295, 400 -01 (S.D.N.Y. 2012) aff'd in part, rev'd in part, 723 F.3d 1363 (Fed. Cir. 2013) cert. granted, 13-854, 2014 WL 199529 (U.S. Mar. 3......
-
Use of Reissue Proceedings in Hatch-Waxman Litigation
...that the ’808 patent was indefinite. On November 5, 2015, Teva then asked the Supreme 51. Teva Pharms. USA, Inc. v. Sandoz, Inc., 876 F. Supp. 2d 295 (S.D.N.Y. 2012), aff’d in part, rev’d in part, 723 F.3d 1363 (Fed. Cir. 2013), judgment vacated, 135 S. Ct. 831. Of the nine patents, seven w......